Patents by Inventor Alessandro Gagnoni

Alessandro Gagnoni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystal forms of immunomodulatory drug pomalidomide and co-crystal with gentisic acid
    Patent number: 10155740
    Abstract: The present invention relates to novel solid crystal forms of Pomalidomide named Form B, Form M, Pomalidomide:Gentisic acid co-crystal and their preparation. Advantageously, these solid forms are used in pharmaceutical compositions for the treatment and the prevention of multiple myeloma, of inflammatory diseases, of autoimmune diseases, of immune diseases, of myelodysplastic syndrome, of myeloproliferative disorders, of anemia, of scleroderma, amyloidosis or of other diseases associated with unwanted angiogenesis.
    Type: Grant
    Filed: November 24, 2016
    Date of Patent: December 18, 2018
    Assignee: F.I.S.—FABBRICA ITALIANA SINTETICI S.P.A
    Inventors: Alessandro Gagnoni, Antonio Germani, Nicolas Tesson
  • CRYSTAL FORMS OF IMMUNOMODULATORY DRUG POMALIDOMIDE AND CO-CRYSTAL WITH GENTISIC ACID
    Publication number: 20180099944
    Abstract: The present invention relates to novel solid crystal forms of Pomalidomide named Form B, Form M, Pomalidomide:Gentisic acid co-crystal and their preparation. Advantageously, these solid forms are used in pharmaceutical compositions for the treatment and the prevention of multiple myeloma, of inflammatory diseases, of autoimmune diseases, of immune diseases, of myelodysplastic syndrome, of myeloproliferative disorders, of anemia, of scleroderma, amyloidosis or of other diseases associated with unwanted angiogenesis.
    Type: Application
    Filed: November 24, 2016
    Publication date: April 12, 2018
    Inventors: Alessandro GAGNONI, Antonio GERMANI, Nicolas TESSON
  • USES OF AMMONIUM CHLORIDE
    Publication number: 20100173020
    Abstract: A method to treat a condition in a patient comprising administering to the patient a therapeutically effective amount of a NH4Cl dosage form, a method for stimulating endogenous interferon production, and related methods, systems and dosage form housings.
    Type: Application
    Filed: January 2, 2009
    Publication date: July 8, 2010
    Inventors: Diamantis KIASSOS, Alessandro Gagnoni
  • Inhalatory compositions of formoterol
    Publication number: 20020155068
    Abstract: Inhalatory pharmaceutical compositions containing Formoterol as active ingredient, comprising:
    Type: Application
    Filed: March 4, 2002
    Publication date: October 24, 2002
    Inventors: Andrea Meoli, Alessandro Gagnoni, Sereno Vanossi
  • Rectal flunisolide compositions for treating inflammatory intestinal disorders
    Patent number: 5721228
    Abstract: Topical rectal therapeutic composition containing, as the active ingredient, flunisolide and/or one or more ester derivatives of same, in combination with suitable excipients and/or diluents, for the treatment of inflammatory intestinal disorders.
    Type: Grant
    Filed: May 17, 1995
    Date of Patent: February 24, 1998
    Assignee: Valeas S.p.A. Industria Chimica E Farmaceutica
    Inventors: Virgilio Bernareggi, Maurizio Fano, Alessandro Gagnoni